Natixis »

Kymera Therapeutics shares owned by Natixis

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Natixis from 13F filings

Historical chart of Natixis investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Natixis consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Natixis

Quarter filed Position value Share count Share price at filing
2025-06-30 $113k 2.6k 43.64
2025-03-31 $356k 13k 28.07
2024-03-31 $80k 2.0k 40.20
2023-09-30 $58k 4.2k 13.90
2022-03-31 $373k 8.8k 42.37
2021-12-31 $1.1M 17k 63.51
2021-09-30 $3.3M 56k 58.75
2021-06-30 $318k 6.6k 48.45